Publications and presentations

28th July 20169th March 2017 Moderator

Selected publications by the UCAN team members

In Press

Dospinescu C, Lam TBL, Kurban L, Cohen NP, Swami KS. Acute pancreatitis induced by an obstructing left ureteric calculus [in press]. BJU International 2011;

Swami KS, Lam T, Nabi G. A novel circumferential bladder neck suture to facilitate vesico-urethral anastomosis during radical retropubic prostatectomy [in press]. BJU International 2011;

2017

Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam TB, MacLennan S, N’Dow J, Babjuk M, Bohle A, Burger M, Compérat E, Cowan NC, Kaasinen E, Palou J, van Rhijn BWG, Sylvester R, Zigeuner R, Shariat SF, Rouprêt M. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an EAU guidelines systematic review. European Urology Focus 2017 (in press)Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam TB, MacLennan S, N’Dow J, Babjuk M, Bohle A, Burger M, Compérat E, Cowan NC, Kaasinen E, Palou J, van Rhijn BWG, Sylvester R, Zigeuner R, Shariat SF, Rouprêt M. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an EAU guidelines systematic review. European Urology Focus 2017 (in press)Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam TB, MacLennan S, N’Dow J, Babjuk M, Bohle A, Burger M, Compérat E, Cowan NC, Kaasinen E, Palou J, van Rhijn BWG, Sylvester R, Zigeuner R, Shariat SF, Rouprêt M. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an EAU guidelines systematic review. European Urology Focus 2017 (in press)

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RC, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan C, Cornford P, Mottet N, Lam TB, Rouvière O. What is the negative predictive value of multiparametric MRI in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the EAU Prostate Cancer Guidelines Panel. European Urology 2017 (in press)Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RC, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan C, Cornford P, Mottet N, Lam TB, Rouvière O. What is the negative predictive value of multiparametric MRI in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the EAU Prostate Cancer Guidelines Panel. European Urology 2017 (in press)Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RC, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan C, Cornford P, Mottet N, Lam TB, Rouvière O. What is the negative predictive value of multiparametric MRI in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the EAU Prostate Cancer Guidelines Panel. European Urology 2017 (in press)

Veskimäe E, Neuzillet Y, Rouanne M, MacLennan S, Lam TB, Yuan Y, Compérat E, Cowan NC, Gakis G, van der Heijden AG, Ribal MJ, Witjes JA, Lebrét T. Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819. [Epub ahead of print]Veskimäe E, Neuzillet Y, Rouanne M, MacLennan S, Lam TB, Yuan Y, Compérat E, Cowan NC, Gakis G, van der Heijden AG, Ribal MJ, Witjes JA, Lebrét T. Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819. [Epub ahead of print]Veskimäe E, Neuzillet Y, Rouanne M, MacLennan S, Lam TB, Yuan Y, Compérat E, Cowan NC, Gakis G, van der Heijden AG, Ribal MJ, Witjes JA, Lebrét T. Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819. [Epub ahead of print]

van der Poel HG, Wit EM, Acar C, van den Berg NS, van Leeuwen FW, Valdes Olmos RA, Winter A, Wawroschek F, Liedberg F, Maclennan S, Lam T. Sentinel node biopsy for prostate cancer: report from a consensus panel meeting. BJU Int. 2017 Feb 10. doi: 10.1111/bju.13810. [Epub ahead of print]van der Poel HG, Wit EM, Acar C, van den Berg NS, van Leeuwen FW, Valdes Olmos RA, Winter A, Wawroschek F, Liedberg F, Maclennan S, Lam T. Sentinel node biopsy for prostate cancer: report from a consensus panel meeting. BJU Int. 2017 Feb 10. doi: 10.1111/bju.13810. [Epub ahead of print]van der Poel HG, Wit EM, Acar C, van den Berg NS, van Leeuwen FW, Valdes Olmos RA, Winter A, Wawroschek F, Liedberg F, Maclennan S, Lam T. Sentinel node biopsy for prostate cancer: report from a consensus panel meeting. BJU Int. 2017 Feb 10. doi: 10.1111/bju.13810. [Epub ahead of print]

Malde S, Nambiar AK, Umbach R, Lam T, Bache T, Bachmann A, Drake MJ, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO, Gravas S. Systematic review of the performance of non-invasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. European Urology 2017 Mar;71(3):391-402. doi: 10.1016/j.eururo.2016.09.026.Malde S, Nambiar AK, Umbach R, Lam T, Bache T, Bachmann A, Drake MJ, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO, Gravas S. Systematic review of the performance of non-invasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. European Urology 2017 Mar;71(3):391-402. doi: 10.1016/j.eururo.2016.09.026.Malde S, Nambiar AK, Umbach R, Lam T, Bache T, Bachmann A, Drake MJ, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO, Gravas S. Systematic review of the performance of non-invasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms. European Urology 2017 Mar;71(3):391-402. doi: 10.1016/j.eururo.2016.09.026.

MacLennan, Sara J.; MacLennan, Steven; Bex, Axel; Catto, James W. F.; De Santis, Maria; Glaser, Adam; Ljungberg, Borje ; N’Dow, James; Plass, Karin; Trapero-Bertran, Marta ; Van Poppel, Hendrik ; Wright, Penny; Giles, Rachel H. Changing Current Practice in Urology : Improving Guideline Development and Implementation Through Stakeholder Engagement. European Urology 2017 (in press)

2016

Kata, S.G., A. Zriek, S. Ahmad et al. “Concurrent bladder cancer in patients undergoing photodynamic diagnostic ureterorenoscopy: how many lesions do we miss under white light cystoscopy?” Central European Journal of Urology 69:334-340. doi: 10.5173 /ceju.2016.896. Nov 2016

Ahmad, S. Zakikhani, P., Gietzman, W. et al “Radiation therapy for Urological cancers.” JCUrol. vol 9.3, 142-150, doi:10.1177/2051415816634564. February 2016

Mubarik, K., Ahmad, S. “Serum biomarkers for sepsis” J Med Diagn Meth 5:1000e113. doi:10.4172/2168-9784-1000e113. Jan 2016

Fossati N, Willemse PM, Van den Broeck T, van den Bergh RC, Yuan CY, Briers E, Bellmunt J, Bolla M, Cornford P, De Santis M, MacPepple E, Henry AM, Mason MD, Matveev VB, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Lam TB, Mottet N, Joniau S. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. European Urology 2017 Jan 24. pii: S0302-2838(16)30900-9. doi: 10.1016/j.eururo.2016.12.003.Fossati N, Willemse PM, Van den Broeck T, van den Bergh RC, Yuan CY, Briers E, Bellmunt J, Bolla M, Cornford P, De Santis M, MacPepple E, Henry AM, Mason MD, Matveev VB, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Lam TB, Mottet N, Joniau S. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. European Urology 2017 Jan 24. pii: S0302-2838(16)30900-9. doi: 10.1016/j.eururo.2016.12.003.Fossati N, Willemse PM, Van den Broeck T, van den Bergh RC, Yuan CY, Briers E, Bellmunt J, Bolla M, Cornford P, De Santis M, MacPepple E, Henry AM, Mason MD, Matveev VB, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Lam TB, Mottet N, Joniau S. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. European Urology 2017 Jan 24. pii: S0302-2838(16)30900-9. doi: 10.1016/j.eururo.2016.12.003.

Fernández-Pello S, Hofmann F, Tahbaz R, Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. European Urology 2017 Mar;71(3):426-436. doi: 10.1016/j.eururo.2016.11.020.Fernández-Pello S, Hofmann F, Tahbaz R, Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. European Urology 2017 Mar;71(3):426-436. doi: 10.1016/j.eururo.2016.11.020.Fernández-Pello S, Hofmann F, Tahbaz R, Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. European Urology 2017 Mar;71(3):426-436. doi: 10.1016/j.eururo.2016.11.020.

Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Staehler M, Volpe A, Powles T. Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma. European Urology 2016 Dec 13. pii: S0302-2838(16)30886-7. doi: 10.1016/j.eururo.2016.11.034.Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Staehler M, Volpe A, Powles T. Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma. European Urology 2016 Dec 13. pii: S0302-2838(16)30886-7. doi: 10.1016/j.eururo.2016.11.034.Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Staehler M, Volpe A, Powles T. Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma. European Urology 2016 Dec 13. pii: S0302-2838(16)30886-7. doi: 10.1016/j.eururo.2016.11.034.

Sylvester RJ, Canfield SE, Lam TB, Marconi L, MacLennan S, Yuan Y, MacLennan G, Norrie J, Omar MI, Bruins HM, Hernández V, Plass K, Van Poppel H, N’Dow J. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. European Urology 2016 Nov 30. pii: S0302-2838(16)30856-9. doi: 10.1016/j.eururo.2016.11.023. [Epub ahead of print]Sylvester RJ, Canfield SE, Lam TB, Marconi L, MacLennan S, Yuan Y, MacLennan G, Norrie J, Omar MI, Bruins HM, Hernández V, Plass K, Van Poppel H, N’Dow J. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. European Urology 2016 Nov 30. pii: S0302-2838(16)30856-9. doi: 10.1016/j.eururo.2016.11.023. [Epub ahead of print]Sylvester RJ, Canfield SE, Lam TB, Marconi L, MacLennan S, Yuan Y, MacLennan G, Norrie J, Omar MI, Bruins HM, Hernández V, Plass K, Van Poppel H, N’Dow J. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. European Urology 2016 Nov 30. pii: S0302-2838(16)30856-9. doi: 10.1016/j.eururo.2016.11.023. [Epub ahead of print]

Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Mottet N. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. European Urology 2016 Aug 31. pii: S0302-2838(16)30469-9. doi: 10.1016/j.eururo.2016.08.002. [Epub ahead of print]Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Mottet N. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. European Urology 2016 Aug 31. pii: S0302-2838(16)30469-9. doi: 10.1016/j.eururo.2016.08.002. [Epub ahead of print]Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Mottet N. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. European Urology 2016 Aug 31. pii: S0302-2838(16)30469-9. doi: 10.1016/j.eururo.2016.08.002. [Epub ahead of print]

Wit EM, Acar C, Grivas N, Yuan C, Horenblas S, Liedberg F, Valdes Olmos RA, van Leeuwen FW, van den Berg NS, Winter A, Wawroschek F, Hruby S, Janetschek G, Vidal-Sicart S, MacLennan S, Lam TB, van der Poel HG. Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy. European Urology 2016 Sep 14. pii: S0302-2838(16)30617-0. doi: 10.1016/j.eururo.2016.09.007. [Epub ahead of print] Review.Wit EM, Acar C, Grivas N, Yuan C, Horenblas S, Liedberg F, Valdes Olmos RA, van Leeuwen FW, van den Berg NS, Winter A, Wawroschek F, Hruby S, Janetschek G, Vidal-Sicart S, MacLennan S, Lam TB, van der Poel HG. Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy. European Urology 2016 Sep 14. pii: S0302-2838(16)30617-0. doi: 10.1016/j.eururo.2016.09.007. [Epub ahead of print] Review.Wit EM, Acar C, Grivas N, Yuan C, Horenblas S, Liedberg F, Valdes Olmos RA, van Leeuwen FW, van den Berg NS, Winter A, Wawroschek F, Hruby S, Janetschek G, Vidal-Sicart S, MacLennan S, Lam TB, van der Poel HG. Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy. European Urology 2016 Sep 14. pii: S0302-2838(16)30617-0. doi: 10.1016/j.eururo.2016.09.007. [Epub ahead of print] Review.

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RC, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology 2016 Aug 25. pii: S0302-2838(16)30470-5. doi: 10.1016/j.eururo.2016.08.003. [Epub ahead of print]Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RC, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology 2016 Aug 25. pii: S0302-2838(16)30470-5. doi: 10.1016/j.eururo.2016.08.003. [Epub ahead of print]

Powles T, Staehler M, Ljungberg B, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Volpe A, Bex A. European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor-Targeted Therapy. European Urology 2016 Jun 24. pii: S0302-2838(16)30279-2. doi: 10.1016/j.eururo.2016.06.009. [Epub ahead of print]Powles T, Staehler M, Ljungberg B, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Volpe A, Bex A. European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor-Targeted Therapy. European Urology 2016 Jun 24. pii: S0302-2838(16)30279-2. doi: 10.1016/j.eururo.2016.06.009. [Epub ahead of print]

Marconi L, Lam TB, Bex A, Ljungberg B, Volpe A. Reply to Jae Heon Kim’s Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. European Urology 2016;69:660-73. 2016 May 4. pii: S0302-2838(16)30136-1. doi: 10.1016/j.eururo.2016.04.026. [Epub ahead of print]Marconi L, Lam TB, Bex A, Ljungberg B, Volpe A. Reply to Jae Heon Kim’s Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. European Urology 2016;69:660-73. 2016 May 4. pii: S0302-2838(16)30136-1. doi: 10.1016/j.eururo.2016.04.026. [Epub ahead of print]

Marconi L, Lam TB, Bex A, Ljungberg B, Volpe A. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. European Urology 2016;69:660-73.Marconi L, Lam TB, Bex A, Ljungberg B, Volpe A. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. European Urology 2016;69:660-73.

van den Bergh RC, van Casteren NJ, van den Broeck T, Fordyce ER, Gietzmann WK, Stewart F, MacLennan S, Dabestani S, Bellmunt J, Bolla M, Briers E, Cornford P, Joniau S, Mason MD, Matveev V, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Lam TB, Mottet N. Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review. European Urology 2016 May;69(5):802-20. doi: 10.1016/j.eururo.2015.11.023. Epub 2015 Dec 12.van den Bergh RC, van Casteren NJ, van den Broeck T, Fordyce ER, Gietzmann WK, Stewart F, MacLennan S, Dabestani S, Bellmunt J, Bolla M, Briers E, Cornford P, Joniau S, Mason MD, Matveev V, van der Poel HG, van der Kwast TH, Rouvière O, Wiegel T, Lam TB, Mottet N. Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review. European Urology 2016 May;69(5):802-20. doi: 10.1016/j.eururo.2015.11.023. Epub 2015 Dec 12.

El-Mokadem I, Kidd T, Pratt N, Fleming S, Nabi GTumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer. Oncotarget. 2016 Nov 8;7(45):73045-73054. doi: 10.18632/oncotarget.12196. PMID: 27682877

MacLennan, Steven; Briganti, Alberto; Grimshaw, Jeremy M; N’Dow, James. Re: Low Adherence to Guidelines in Nonmuscle-invasive Disease. European Urology 2016; Vol. 71, No. 4, 01.04.2017, p. 689.

Brennand, Catherine; von Wilamowitz-Moellendorff, Alexander; Dunn, Sarah; Wilkinson, Jennifer; Chadwick, Thomas; Ternent, Laura; Oluboyede, Yemi; Wood, Ruth; Walton, Katherine; Fader, Mandy; N’Dow, James; Abdel-Fattah, Mohamed; McClurg, Doreen; Little, Paul; Hilton, Paul; Timoney, Anthony; Morris, Nicola; Thiruchelvam, Nikesh; Larcombe, James; Harrison, Simon; Armstrong, Heather; McColl, Elaine; Pickard, Robert. Antibiotic treatment for intermittent bladder catheterisation with once daily prophylaxis (the AnTIC study) : Study protocol for a randomised controlled trial. Trials 2016; Vol. 17, 276, 04.06.2016, p. 1-18

Briganti, Alberto; MacLennan, Steven; Marconi, Lorenzo; Plass, Karin; N’Dow, James; EAU Guidelines Office ‘IMAGINE’ project. European Association of Urology (EAU) guidelines : do we care? Reflections from the EAU Impact Assessment of Guidelines Implementation and Education group. BJU International 2016; Vol. 117, No. 6, 06.2016, p. 850-851.

Sylvester, Richard J; Oosterlinck, Willem; Holmang, Sten; Sydes, Matthew R; Birtle, Alison; Gudjonsson, Sigurdur; De Nunzio, Cosimo; Okamura, Kikuo; Kaasinen, Eero; Solsona, Eduardo; Ali-El-Dein, Bedeir; Tatar, Can Ali; Inman, Brant A; N’Dow, James; Oddens, Jorg R; Babjuk, Marek. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? European Urology 2016; Vol. 69, No. 2, 02.2016, p. 231-244.

Pickard, R.; Starr, K.; MacLennan, G.; Lam, T.; Thomas, R.; Burr, J.; McPherson, G.; McDonald, A.; Anson, K.; N’Dow, J.; Burgess, N.; Clark, T.; Kilonzo, M.; Gillies, K.; Shearer, K.; Boachie, C.; Cameron, S.; Norrie, J.; McClinton, S. Kurzdarstellung aktueller publikationen : Begünstigt eine muskelrelaxierende therapie den uretersteinabgang? Nieren- und Hochdruckkrankheiten 2016; Vol. 45, No. 1, p. 38.

2015

Kata, S.G., Aboumarzouk, O., Zriek, A., Somani, B., Ahmad, S. et al. “Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour”. Photodignosis Photodyn Ther. doi: 10.1016/j.pdpdt.2015.08.002. Aug 2015Kata, S.G., Aboumarzouk, O., Zriek, A., Somani, B., Ahmad, S. et al. “Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour”. Photodignosis Photodyn Ther. doi: 10.1016/j.pdpdt.2015.08.002. Aug 2015

Ahmad, S. “Robotic assisted radical cystectomy, current status and future directions.” Med Surg Urol 4:e111. doi:10.4172/2168-9857.1000e111. April 2015Ahmad, S. “Robotic assisted radical cystectomy, current status and future directions.” Med Surg Urol 4:e111. doi:10.4172/2168-9857.1000e111. April 2015

Aboumarzouk, O., Valentine, R., Buist, R., Ahmad, S., et al. “Laser-induced autofluorescence spectoroscopy: can it be of importance in detection of bladder lesions?” Photodignosis Photodyn Ther. doi: 10.1016/j.pdpdt.2014.12.003. Jan 2015Aboumarzouk, O., Valentine, R., Buist, R., Ahmad, S., et al. “Laser-induced autofluorescence spectoroscopy: can it be of importance in detection of bladder lesions?” Photodignosis Photodyn Ther. doi: 10.1016/j.pdpdt.2014.12.003. Jan 2015

Lardas M, Stewart F, Scrimgeour D, Hofmann F, Marconi L, Dabestani S, Bex A, Volpe A, Canfield SE, Staehler M, Hora M, Powles T, Merseburger AS, Kuczyk MA, Bensalah K, Mulders PF, Ljungberg B, Lam TB. Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. European Urology 2015 Dec 23. pii: S0302-2838(15)01205-1. doi: 10.1016/j.eururo.2015.11.034. [Epub ahead of print]Lardas M, Stewart F, Scrimgeour D, Hofmann F, Marconi L, Dabestani S, Bex A, Volpe A, Canfield SE, Staehler M, Hora M, Powles T, Merseburger AS, Kuczyk MA, Bensalah K, Mulders PF, Ljungberg B, Lam TB. Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. European Urology 2015 Dec 23. pii: S0302-2838(15)01205-1. doi: 10.1016/j.eururo.2015.11.034. [Epub ahead of print]

Powles T, Staehler M, Ljungberg B, Bensalah K, Canfield SE, Dabestani S, Giles R, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Volpe A, Bex A. Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. European Urology 2015 Oct 24. pii: S0302-2838(15)00998-7. doi: 10.1016/j.eururo.2015.10.017. [Epub ahead of print]

MacLennan S, Williamson PR, Lam TB. Letter to the editor Re: Martin NE, Massey L, Stowell C, et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. European Urology 2015 Dec;68(6):e123-4. doi: 10.1016/j.eururo.2015.08.015. Epub 2015 Aug 29.
Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, Bex A, Bensalah K, Canfield S, Hora M, Kuczyk MA, Merseburger AS, Mulders PFA, Powles T, Staehler M, Ljungberg B, Volpe A. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal biopsy. European Urology 2015 Aug 28. pii: S0302-2838(15)00741-1. doi: 10.1016/j.eururo.2015.07.072. [Epub ahead of print]

Pickard R, Starr K, MacLennan G, Kilonzo M, Lam T, Thomas R, Burr J, Norrie J, McPherson G, McDonald A, Shearer K, Gillies K, Anson K, Boachie C, N’Dow J, Burgess N, Clark T, Cameron S, McClinton S. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial). Health Technol Assess. 2015 Aug; 19(63):1-172. doi: 10.3310/hta19630.

Ramsay CR, Adewuyi TE, Gray J, Hislop J, Shirley MD, Jayakody S, MacLennan G, Fraser C, MacLennan S, Brazzelli M, N’Dow J, Pickard R, Robertson C, Rothnie K, Rushton SP, Vale L, Lam TB. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technol Assess. 2015 Jul; 19(49):1-490. doi: 10.3310/hta19490.

Robertson C, Cummins E, Fielding S, Lam T, Fraser C, Ramsay CR. Enzalutamide for treating metastatic hormone-relapsed prostate cancer not previously treated with chemotherapy: a single technology appraisal. Aberdeen HTA Group, 2015.

Pickard R, Starr K, Thomas RE, MacLennan G, Lam T, Burr J, McPherson G, McDonald A, Anson K, N’Dow JMD, Burgess N, Clark T, Kilonzo M, Gillies K, Boachie C, Shearer K, Cameron S, Norrie J, McClinton S. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet (Published online May 19, 2015 http://dx.doi.org/10.1016/S0140-6736(15)60933-3)

N. Mottet (Chair), J. Bellmunt, E. Briers (Patient Representative), R.C.N. van den Bergh (Guidelines Associate), M. Bolla, N.J. van Casteren (Guidelines Associate), P. Cornford, S. Culine, S. Joniau, T. Lam, M.D. Mason, V. Matveev, H. van der Poel, T.H. van der Kwast, O. Rouvière, T. Wiegel. European Association of Urology Guidelines on Prostate Cancer (2015 update). [document on the Internet]. European Association of Urology, 2015. [Accessed May 2015]. Available from URL:http://uroweb.org/wp-content/uploads/09-Prostate-Cancer_LR.pdf

B. Ljungberg (Chair), K. Bensalah, A. Bex (Vice-chair), S. Canfield, S. Dabestani (Guidelines Associate), R.H. Giles (Patient Advocate), F. Hofmann (Guidelines Associate), M. Hora, M.A. Kuczyk, T. Lam, L. Marconi (Guidelines Associate), A.S. Merseburger, T. Powles, M. Staehler, A. Volpe. European Association of Urology Guidelines on Renal Cell Carcinoma (2015 update). [document on the Internet]. European Association of Urology, 2015. [Accessed May 2015]. Available from URL:http://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_LR1.pdf

MacLennan S, Bekema HJ, Williamson PR, Campbell MK, Stewart F, MacLennan SJ, N’Dow J, Lam T. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey. Trials 2015, 16:76 (4 March 2015) (http://dx.doi.org/10.1186/s13063-015-0598-0)
Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. European Urology 2015 May; 67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21.
Ahmad S, Lam TBL, N’Dow J. Significance of MUC-1 in bladder cancer. BJU Int. 2015 Jan;115(1):161-2. doi: 10.1111/bju.12727.
Robertson C, Lam T, Stewart F, Scott NW, Cummins E, Ramsay CR. Single technology appraisal: Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases [ID576]. Aberdeen HTA Group, Institute of Applied Health Sciences, University of Aberdeen, 2013. Available from URL: http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0010/115021/ERGReport-12-57-01.pdf

Mishriki SF, Aboumarzouk O, Somani B. Vasectomy, pain, sexual dysfunction & relationship breakdown. BJUI 2015; 115 (Suppl. 7): 34.
Ghaemi J, El-Mokadem I, Coles B, Baker L, Dahm P, Canfield SE, Nabi G. Safety and diagnostic accuracy of image guided biopsies in patients with small renal masses (Protocol). Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD011936. doi: 10.1002/14651858.CD011936.Protocol.
Mariappan P, Rai B, El-Mokadem I, Anderson CH, Lee H, Stewart S, Donat R. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis–assisted Transurethral Resection of Bladder Tumour (TURBT) vs Good-quality White Light TURBT in New Non–muscle-invasive Bladder Cancer. Urology. 2015 Aug;86(2):327-31. doi: 10.1016/j.urology.2015.04.015. Epub 2015 Jul 2. PMID: 26142924

Gillan A, El-Mokadem I, Rai B, Lang S, Alcorn J, ShamsUddin A, Dasgupta R, Biyani CS, Nabi G. Carcinoma In-Situ Is significantly underdetected by pre-nephroureterectomyureteroscopy in the management of upper tract urothelial cancers. Biomed Res Int. 2015:547586. doi: 10.1155/2015/547586. Epub 2015 Jan 15. PMID: 25654112.Gillan A, El-Mokadem I, Rai B, Lang S, Alcorn J, ShamsUddin A, Dasgupta R, Biyani CS, Nabi G. Carcinoma In-Situ Is significantly underdetected by pre-nephroureterectomyureteroscopy in the management of upper tract urothelial cancers. Biomed Res Int. 2015:547586. doi: 10.1155/2015/547586. Epub 2015 Jan 15. PMID: 25654112.Gillan A, El-Mokadem I, Rai B, Lang S, Alcorn J, ShamsUddin A, Dasgupta R, Biyani CS, Nabi G. Carcinoma In-Situ Is significantly underdetected by pre-nephroureterectomyureteroscopy in the management of upper tract urothelial cancers. Biomed Res Int. 2015:547586. doi: 10.1155/2015/547586. Epub 2015 Jan 15. PMID: 25654112.

Stephenson, Rachel; Carnell, Sonya; Johnson, Nicola; Brown, Robbie; Wilkinson, Jennifer; Mundy, Anthony; Payne, Steven; Watkin, Nick; N’Dow, James; Sinclair, Andrew; Rees, Rowland; Barclay, Stewart; Cook, Jonathan A; Goulao, Beatriz; MacLennan, Graeme; McPherson, Gladys; Jackson, Matthew; Rapley, Tim; Shen, Jing; Vale, Luke; Norrie, John; McColl, Elaine; Pickard, Robert. Open urethroplasty versus endoscopic urethrotomy – clarifying the management of men with recurrent urethral stricture (the OPEN trial) : study protocol for a randomised controlled trial. Trials 2015; Vol. 16, 600.

Mohamad, Hamdan; McNeill, Geraldine; Haseen, Farhana; N’Dow, James; Craig, Leone C A; Heys, Steven D. The Effect of Dietary and Exercise Interventions on Body Weight in Prostate Cancer Patients : A Systematic Review. Nutrition and Cancer 2015; Vol. 67, No. 1, 2015, p. 43-60.

2014

Ahmad, S., T. B. Lam, J. N’ Dow “Significance of MUC1 in bladder cancer.” BJU Int, 115 (1): 161-2. doi: 10.1111/bju.12727. Dec 2014Ahmad, S., T. B. Lam, J. N’ Dow “Significance of MUC1 in bladder cancer.” BJU Int, 115 (1): 161-2. doi: 10.1111/bju.12727. Dec 2014Ahmad, S., T. B. Lam, J. N’ Dow “Significance of MUC1 in bladder cancer.” BJU Int, 115 (1): 161-2. doi: 10.1111/bju.12727. Dec 2014
Saliev, T., Karakitsios, I., Ahmad, S., et al. “Validation of structural effects mediated by MR-guided focused ultrasound on animal kidney ex vivo model”. Jou of Solid Tumours 4,18 – 24. doi: 10.5430/jst.v4np18. April 2014

Ahmad, S., Atkin, L., Wilson, J., et al. “Endometrioid endometrial carcinoma of the urinary bladder – a diagnostic challenge.” Med Diagn Meth 3: 155. doi:10.4172/2168-9784.1000155. March 2014

Ahmad, S. “Fusion of MRI and TRUS images for targeted biopsy of prostate” Med Surg Urol 3: e108. doi:10.4172/2168-9857.1000e108. March 2014
Donaldson JF, Lardas M, Scrimgeour D, Stewart F, MacLennan S, Lam TB, McClinton S. Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PNL) for lower pole renal stones. European Urology 2014 Oct 23. pii: S0302-2838(14)01005-7. doi: 10.1016/j.eururo.2014.09.054. [Epub ahead of print]Donaldson JF, Lardas M, Scrimgeour D, Stewart F, MacLennan S, Lam TB, McClinton S. Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PNL) for lower pole renal stones. European Urology 2014 Oct 23. pii: S0302-2838(14)01005-7. doi: 10.1016/j.eururo.2014.09.054. [Epub ahead of print]Donaldson JF, Lardas M, Scrimgeour D, Stewart F, MacLennan S, Lam TB, McClinton S. Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PNL) for lower pole renal stones. European Urology 2014 Oct 23. pii: S0302-2838(14)01005-7. doi: 10.1016/j.eururo.2014.09.054. [Epub ahead of print]

Lam TBL, Omar MI, Fisher E, Gillies K, MacLennan S. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014 Sep 23;9:CD004013. [Epub ahead of print]Lam TBL, Omar MI, Fisher E, Gillies K, MacLennan S. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014 Sep 23;9:CD004013. [Epub ahead of print]Lam TBL, Omar MI, Fisher E, Gillies K, MacLennan S. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014 Sep 23;9:CD004013. [Epub ahead of print]
Lam TBL, McClinton S. Between a rock and a hard place: The uncertainties in managing renal stones. European Urology 2014 Jul 31. pii: S0302-2838(14)00668-X. doi: 10.1016/j.eururo.2014.07.016. [Epub ahead of print]Lam TBL, McClinton S. Between a rock and a hard place: The uncertainties in managing renal stones. European Urology 2014 Jul 31. pii: S0302-2838(14)00668-X. doi: 10.1016/j.eururo.2014.07.016. [Epub ahead of print]Lam TBL, McClinton S. Between a rock and a hard place: The uncertainties in managing renal stones. European Urology 2014 Jul 31. pii: S0302-2838(14)00668-X. doi: 10.1016/j.eururo.2014.07.016. [Epub ahead of print]

McClinton S, Starr K, Thomas R, McLennan G, McPherson G, McDonald A, Lam T, N Dow J, Kilonzo M, Pickard R, Anson K, Burr J. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an alpha-blocker (tamsulosin): study protocol for a randomized controlled trial. Trials. 2014 Jun 20;15(1):238. [Epub ahead of print]McClinton S, Starr K, Thomas R, McLennan G, McPherson G, McDonald A, Lam T, N Dow J, Kilonzo M, Pickard R, Anson K, Burr J. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an alpha-blocker (tamsulosin): study protocol for a randomized controlled trial. Trials. 2014 Jun 20;15(1):238. [Epub ahead of print]McClinton S, Starr K, Thomas R, McLennan G, McPherson G, McDonald A, Lam T, N Dow J, Kilonzo M, Pickard R, Anson K, Burr J. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an alpha-blocker (tamsulosin): study protocol for a randomized controlled trial. Trials. 2014 Jun 20;15(1):238. [Epub ahead of print]

Kilonzo M, Vale L, Pickard R, Lam T, N’Dow J; for the Catheter Trial Group. Cost effectiveness of antimicrobial catheters for adults requiring short-term catheterisation in hospital. European Urology 2014 Jun 20. pii: S0302-2838(14)00517-X. doi: 10.1016/j.eururo.2014.05.035. [Epub ahead of print] Kilonzo M, Vale L, Pickard R, Lam T, N’Dow J; for the Catheter Trial Group. Cost effectiveness of antimicrobial catheters for adults requiring short-term catheterisation in hospital. European Urology 2014 Jun 20. pii: S0302-2838(14)00517-X. doi: 10.1016/j.eururo.2014.05.035. [Epub ahead of print] Kilonzo M, Vale L, Pickard R, Lam T, N’Dow J; for the Catheter Trial Group. Cost effectiveness of antimicrobial catheters for adults requiring short-term catheterisation in hospital. European Urology 2014 Jun 20. pii: S0302-2838(14)00517-X. doi: 10.1016/j.eururo.2014.05.035. [Epub ahead of print]

Bruins M, Veskimae E, Hernandez V, Imamura M, Neuberger M, Dahm P, Stewart F, Lam T, N’dow J, van der Heijden AG, Compérat E, Cowan NC, de Santis M, Gakis G, Lebret T, Ribal MJ, Sherif A, Witjes JA. The impact of the extent of lymphadenectomy on oncological outcomes in patients undergoing radical cystectomy for bladder cancer: A systematic review. European Urology 2014 Jul 26. pii: S0302-2838(14)00491-6. doi: 10.1016/j.eururo.2014.05.031. [Epub ahead of print]Bruins M, Veskimae E, Hernandez V, Imamura M, Neuberger M, Dahm P, Stewart F, Lam T, N’dow J, van der Heijden AG, Compérat E, Cowan NC, de Santis M, Gakis G, Lebret T, Ribal MJ, Sherif A, Witjes JA. The impact of the extent of lymphadenectomy on oncological outcomes in patients undergoing radical cystectomy for bladder cancer: A systematic review. European Urology 2014 Jul 26. pii: S0302-2838(14)00491-6. doi: 10.1016/j.eururo.2014.05.031. [Epub ahead of print]Bruins M, Veskimae E, Hernandez V, Imamura M, Neuberger M, Dahm P, Stewart F, Lam T, N’dow J, van der Heijden AG, Compérat E, Cowan NC, de Santis M, Gakis G, Lebret T, Ribal MJ, Sherif A, Witjes JA. The impact of the extent of lymphadenectomy on oncological outcomes in patients undergoing radical cystectomy for bladder cancer: A systematic review. European Urology 2014 Jul 26. pii: S0302-2838(14)00491-6. doi: 10.1016/j.eururo.2014.05.031. [Epub ahead of print]

Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncology 2014 Nov; 15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9. Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncology 2014 Nov; 15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9. Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncology 2014 Nov; 15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9.

Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Powles T, Staehler M, Volpe A. European Association of Urology Guidelines on Renal Cell Carcinoma (2014 update). [document on the Internet]. European Association of Urology, 2014. [Accessed April 2014]. Available from URL: http://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_LR.pdfLjungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Powles T, Staehler M, Volpe A. European Association of Urology Guidelines on Renal Cell Carcinoma (2014 update). [document on the Internet]. European Association of Urology, 2014. [Accessed April 2014]. Available from URL: http://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_LR.pdfLjungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Powles T, Staehler M, Volpe A. European Association of Urology Guidelines on Renal Cell Carcinoma (2014 update). [document on the Internet]. European Association of Urology, 2014. [Accessed April 2014]. Available from URL: http://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_LR.pdf

Albiges L, Choueiri T, Escudier B, Galsky M, George D, Hofmann F, Lam T, Motzer R, Mulders P, Porta C, Powles T, Sternberg C, Bex A. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer. European Urology 2015 Jan; 67(1):100-10. doi: 10.1016/j.eururo.2014.04.006.Albiges L, Choueiri T, Escudier B, Galsky M, George D, Hofmann F, Lam T, Motzer R, Mulders P, Porta C, Powles T, Sternberg C, Bex A. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer. European Urology 2015 Jan; 67(1):100-10. doi: 10.1016/j.eururo.2014.04.006.Albiges L, Choueiri T, Escudier B, Galsky M, George D, Hofmann F, Lam T, Motzer R, Mulders P, Porta C, Powles T, Sternberg C, Bex A. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer. European Urology 2015 Jan; 67(1):100-10. doi: 10.1016/j.eururo.2014.04.006.

Donaldson JF, Tait C, Rad M, Walker S, Lam T, Abdel-Fattah M, Swami SK. Obstructive uropathy and vesico-vaginal fistula secondary to a retained sex toy in the vagina. J Sex Med. 2014 Oct; 11(10):2595-600. doi: 10.1111/jsm.12575 [Epub ahead of print].Donaldson JF, Tait C, Rad M, Walker S, Lam T, Abdel-Fattah M, Swami SK. Obstructive uropathy and vesico-vaginal fistula secondary to a retained sex toy in the vagina. J Sex Med. 2014 Oct; 11(10):2595-600. doi: 10.1111/jsm.12575 [Epub ahead of print].

El-Mokadem I, Fitzpatrick J, Bondad J, Rauchhaus P, Cunningham J, Pratt N, Fleming S, Nabi G. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery. Br J Cancer. 2014 Sep23;111(7):1381-90. doi: 10.1038/bjc.2014.420. Epub 2014 Aug 19. PMID: 25137021

El-Mokadem I, Budak M, Pillai S, Lang S, Doull R, Goodman C, Nabi G. Progression, inter-observer agreement, and malignancy rate in complex renal cysts (≥Bosniak category IIF). UrolOncol. 2014 Jan;32(1):24.e21-7. doi:10.1016/j.urolonc.2012.08.018. Epub 2013 Feb 6. PMID: 23395236
Skea, Z C; MacLennan, S J; Entwistle, V A; N’dow, J. Communicating good care : A qualitative study of what people with urological cancer value in interactions with health care providers. European Journal of Oncology Nursing 2014; Vol. 18, No. 1, p. 35-40.

2013

Ahmad, S., Byrne, D., Nabi. G., et al. “Training model for transurethral resection of prostate using human cadavers embalmed by Thiel’s method.” Journal of Endourology, Part B: Videourology, 27 (6), doi: 10.1089/vid.2013.0026. Nov 2013

Aboumarzouk, O., Somani, B., Ahmad, S., et al. “Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma.” Urol Ann. 5 (3):184 – 9. doi: 10.4103/0974-7796.115746. July 2013

Ahmad, S., R. Cao, G. Nabi et al. “Transrectal quantitative shear wave elastography in the detection and characterisation of prostate cancer.” Surg Endosc 27 (9): 3280 – 7. doi:10. 1007/s00464-013-2906-7. March 2013Ahmad, S., R. Cao, G. Nabi et al. “Transrectal quantitative shear wave elastography in the detection and characterisation of prostate cancer.” Surg Endosc 27 (9): 3280 – 7. doi:10. 1007/s00464-013-2906-7. March 2013
Makuta G, Chrysafis M, Lam T. Measuring the efficacy of antimicrobial catheters. Nurs Times 2013 Nov 6-12; 109(44):16, 18-9. Makuta G, Chrysafis M, Lam T. Measuring the efficacy of antimicrobial catheters. Nurs Times 2013 Nov 6-12; 109(44):16, 18-9.

Laing KA, Bramwell SP, McNeill A, Corr BD, Lam TBL. Prostate cancer in Scotland: Does Geography matter? An analysis of incidence, disease characteristics and survival between urban and rural areas. Journal of Clinical Urology. doi: 10.1177/2051415813512303 [Published online 28 November 2013 in advance of print journal].Laing KA, Bramwell SP, McNeill A, Corr BD, Lam TBL. Prostate cancer in Scotland: Does Geography matter? An analysis of incidence, disease characteristics and survival between urban and rural areas. Journal of Clinical Urology. doi: 10.1177/2051415813512303 [Published online 28 November 2013 in advance of print journal].

Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M, Maclennan S, Stewart F, N
‘dow J. Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). BJU Int. 2013 Jun 13. doi: 10.1111/bju.12281. [Epub ahead of print].Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M, Maclennan S, Stewart F, N’dow J. Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). BJU Int. 2013 Jun 13. doi: 10.1111/bju.12281. [Epub ahead of print].

Bekema HJ, Maclennan S, Imamura M, Lam TBL, Stewart F, Scott N, MacLennan G, McClinton S, Griffiths TRL, Skolarikos A, MacLennan SJ, Sylvester R, Ljungberg B, N’Dow J. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. European Urology 2013 Nov; 64(5):799-810. Bekema HJ, Maclennan S, Imamura M, Lam TBL, Stewart F, Scott N, MacLennan G, McClinton S, Griffiths TRL, Skolarikos A, MacLennan SJ, Sylvester R, Ljungberg B, N’Dow J. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. European Urology 2013 Nov; 64(5):799-810.
Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C, Kurban L, Lam TB, Padhani AR, Royle J, Scheenen TW, Tassie E.The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. Health Technology Assessment 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200.Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C, Kurban L, Lam TB, Padhani AR, Royle J, Scheenen TW, Tassie E.The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. Health Technology Assessment 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200.
Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Staehler M, Volpe A. Guidelines on renal cell carcinoma [document on the Internet]. European Association of Urology, 2013. [Accessed April 2013]. Available from URL: http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LR.pdf.Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Staehler M, Volpe A. Guidelines on renal cell carcinoma [document on the Internet]. European Association of Urology, 2013. [Accessed April 2013]. Available from URL: http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LR.pdf.

MacLennan S, Lam T, Imamura M, Dahm P, Canfield S, Ljungberg B, N’Dow J. Letter to the editor Re: comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis: s. P. Kim, R. H. Thompson, s. A. Boorjian, C. J. Weight, L. C. Han, m. H. Murad, N. D. Shippee, p. J. Erwin, B. A. Costello, g. K. Chow and B. C. Leibovich j urol 2012; 188: 51-57. J Urol. 2013 Mar; 189(3):1166-7. (doi: 10.1016/j.juro.2012.10.025).MacLennan S, Lam T, Imamura M, Dahm P, Canfield S, Ljungberg B, N’Dow J. Letter to the editor Re: comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis: s. P. Kim, R. H. Thompson, s. A. Boorjian, C. J. Weight, L. C. Han, m. H. Murad, N. D. Shippee, p. J. Erwin, B. A. Costello, g. K. Chow and B. C. Leibovich j urol 2012; 188: 51-57. J Urol. 2013 Mar; 189(3):1166-7. (doi: 10.1016/j.juro.2012.10.025).

Mishriki SF, Aboumarzouk O, Graham JT, Lam TB, Somani BK. Baseline symptom score and flow rate can predict failure of medical treatment of lower urinary tract symptoms: prospective 12-year follow-up study. Urology. 2013 ;81(2):390-4.Mishriki SF, Aboumarzouk O, Graham JT, Lam TB, Somani BK. Baseline symptom score and flow rate can predict failure of medical treatment of lower urinary tract symptoms: prospective 12-year follow-up study. Urology. 2013 ;81(2):390-4.

Aboumarzouk O., Mishriki S., Somani B., Vint R., Lam T. Visible haematuria in patients under 40 years of age: Where do we stand? Eur Urol Suppl 2013;12;e370.

Mishriki S., Somani B., Vint R., Lam T. Visible haematuria in patients under 40 years – Prospective study with 3-11 years follow-up. J Urol 2013;189 (6):2012-3.

Tissingh EJ and Mishriki SF (2013). Risk Factors for Benign Hyperplasia and Urinary Retention. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 15-32.

Rai B, Rajan P, Cohen NP and Mishriki SF (2013). Non-Surgical Management of Benign Prostatic Hyperplasia. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 33-60.

Ng Y and Mishriki SF (2013). TURP and Open Prostatectomy for Benign Prostatic Hyperplasia. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 61-88.

McLornan L, Ng Y and Mishriki SF (2013). Lasers and Minimally Invasive Procedures for Benign Prostatic Hyperplasia. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 89-108.

Sweeney C, Nabi G and Mishriki SF (2013). Overview of Prostate Cancer in Europe and the United States. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp.

Kurban L, Cohen NP and Mishriki SF (2013). Diagnosis of Prostate Cancer – Imaging. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 177-206.

Graham J, Royle J and Mishriki SF (2013). What Is Active Surveillance for Prostate Cancer? In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 207-218.

Graham J, Royle J and Mishriki SF (2013). Radical Treatment for Localized Prostate Cancer. In: Mishriki, S F. (Ed.), The Benign and Malignant Prostate. New York. Nova Science Publishers, pp. 219-248

Sole editor of The Benign and Malignant Prostate. Nova Science Publishers, New York, Published December 2013.

Mostafa, Alyaa; Agur, Wael; Abdel-All, Mohamed; Guerrero, Karen; Lim, Chu; Allam, Mohamed; Yousef, Mohamed; N’Dow, James; Abdel-Fattah, Mohamed. Multicenter prospective randomized study of single-incision mini-sling vs tension-free vaginal tape-obturator in management of female stress urinary incontinence: A minimum of 1-year follow-up. Urology 2013; Vol. 82, No. 3, p. 552-559.

Kazimierczak, Karolina A.; Skea, Zoe C.; Dixon-Woods, Mary; Entwistle, Vikki A.; Feldman-Stewart, Deb; N’dow, James M. O.; MacLennan, Sara J. Provision of cancer information as a “support for navigating the knowledge landscape”: Findings from a critical interpretive literature synthesis. European Journal of Oncology Nursing 2013; Vol. 17, No. 3, p. 360-369.

Mohamad, Hamdan; Haseen, Farhana; Craig, Leone Christina Agnese; Heys, Steven Darryll; N’Dow, James Michael Olu; McNeill, Geraldine. The effect of dietary and exercise interventions on body weight in men diagnosed with prostate cancer: A systematic review. Obesity Facts 2013; Vol. 6, No. Suppl.1, p. 118-119.

Mostafa, Alyaa; N’Dow, James; Abdel-Fattah, Mohamed. Factors influencing women’s decision to participate or not in a surgical randomised controlled trial for surgical treatment of female stress urinary incontinence. BioMed Research International 2013, Vol. 2013, 139813.

2012

Ahmad, S., Aboumarzouk, O., Somani, B., et al. “Oral 5 – aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma – a prospective audit.” BJU Int 110 (11 Pt B): 596-600. doi: 10.1111/j.1464-410X.2012.11326.x. Dec. 2012
Ahmad, S. “Photodynamic diagnosis of upper urinary tract urothelial cell carcinoma.” Med Surg Urol 2:e105. doi: 10.4172/2168-9857.1000e105. Dec. 2012

Ahmad, S., G. Casey, P. Sweeney, et al. “DNA vaccination for prostate cancer, from preclinical to clinical trials – where we stand?” Genet Vaccines Ther 10 (1): 9. doi:10.1186/1479-0556-10-9. Oct. 2012Ahmad, S., G. Casey, P. Sweeney, et al. “DNA vaccination for prostate cancer, from preclinical to clinical trials – where we stand?” Genet Vaccines Ther 10 (1): 9. doi:10.1186/1479-0556-10-9. Oct. 2012Ahmad, S., G. Casey, P. Sweeney, et al. “DNA vaccination for prostate cancer, from preclinical to clinical trials – where we stand?” Genet Vaccines Ther 10 (1): 9. doi:10.1186/1479-0556-10-9. Oct. 2012Ahmad, S., G. Casey, P. Sweeney, et al. “DNA vaccination for prostate cancer, from preclinical to clinical trials – where we stand?” Genet Vaccines Ther 10 (1): 9. doi:10.1186/1479-0556-10-9. Oct. 2012

Karakitsios, I, Saliev, T., McLeod, H., Ahmad, S., et al. “Response of Thiel-embalmed human liver and kidney to MR- guided focused ultrasound surgery.” Biomed Tech (Berl). 57 (s1). doi: 10.1515/bmt-2012-4380. Aug. 2012

Ahmad, S., “Trnasrectal elastosonography for prostate cancer,” J Med Diagn Meth 1:e104. doi: 10.4172/2168-9784.1000e104. July 2012
Cullen, I., Manecksha, R., McCullagh, E., Ahmad, S., et al. “An 11-year of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999–2009.” Ir J Med Sci. 182 (1):81-9. doi: 10.1007/s11845-012-0834-5. June 2012

Aboumarzouk, O., Ahmad, S., Moseley, H., et al.” Accuracy of photodynamic diagnosis in the detection and follow-up of patients with upper urinary tract lesions: Initial 3-year experience.” Arab Journal of Urology 10 (2). doi:10.1016/j.aju.2012.01.006. June 2012

Manecksha, R. P., Cullen, I. M., Ahmad, S., et al.” Prospective randomized controlled trial comparing trigonal versus trigone-sparing intradetrusor injection of botulinum toxin A for refractory idiopathic detrusor over activity.”Eur Urol. 61 (5):928-35, doi: 10.1016/j.eururo. 2011.10.043. May 2012

Ahmad, S., O’Kelly, F., Manecksha, R. P., et al. “Survival after incidental prostate cancer diagnosis at transurethral resection of prostate – 10 year outcomes.” Ir J Med Sci. 181(1):27-31. doi: 10.1007/s11845-011-0753-x. March 2012

Mishriki SF, Aboumarzouk O, Graham JT, Lam TB, Somani BK. Baseline symptom score and flow rate can predict failure of medical treatment of lower urinary tract symptoms: prospective 12-year follow-up study. Urology 2013 Feb; 81(2):390-4. (doi: 10.1016/j.urology.2012.08.104).Mishriki SF, Aboumarzouk O, Graham JT, Lam TB, Somani BK. Baseline symptom score and flow rate can predict failure of medical treatment of lower urinary tract symptoms: prospective 12-year follow-up study. Urology 2013 Feb; 81(2):390-4. (doi: 10.1016/j.urology.2012.08.104).Mishriki SF, Aboumarzouk O, Graham JT, Lam TB, Somani BK. Baseline symptom score and flow rate can predict failure of medical treatment of lower urinary tract symptoms: prospective 12-year follow-up study. Urology 2013 Feb; 81(2):390-4. (doi: 10.1016/j.urology.2012.08.104).Mishriki SF, Aboumarzouk O, Graham JT, Lam TB, Somani BK. Baseline symptom score and flow rate can predict failure of medical treatment of lower urinary tract symptoms: prospective 12-year follow-up study. Urology 2013 Feb; 81(2):390-4. (doi: 10.1016/j.urology.2012.08.104).

Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N’Dow J. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012 Dec 1; 380(9857):1927-35. (doi: 10.1016/S0140-6736(12)61380-4).Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N’Dow J. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012 Dec 1; 380(9857):1927-35. (doi: 10.1016/S0140-6736(12)61380-4).Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N’Dow J. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012 Dec 1; 380(9857):1927-35. (doi: 10.1016/S0140-6736(12)61380-4).Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N’Dow J. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012 Dec 1; 380(9857):1927-35. (doi: 10.1016/S0140-6736(12)61380-4).
Pickard R, Lam TB, Boachie C, MacLennan G, Kilonzo M, Starr K, Duncan A, Pflanz-Sinclair C, McPherson G, Schumm K, Burr J, Walton K, Vale L, Buckley B, McDonald A, Grant A, Glazener C, Norrie J & N’Dow JMO. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial of antibiotic and antiseptic impregnated urethral catheters (The Catheter Trial). Health Technology Assessment 2012 Nov; 16(47):1-197. (doi: 10.3310/hta16470).Pickard R, Lam TB, Boachie C, MacLennan G, Kilonzo M, Starr K, Duncan A, Pflanz-Sinclair C, McPherson G, Schumm K, Burr J, Walton K, Vale L, Buckley B, McDonald A, Grant A, Glazener C, Norrie J & N’Dow JMO. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial of antibiotic and antiseptic impregnated urethral catheters (The Catheter Trial). Health Technology Assessment 2012 Nov; 16(47):1-197. (doi: 10.3310/hta16470).Pickard R, Lam TB, Boachie C, MacLennan G, Kilonzo M, Starr K, Duncan A, Pflanz-Sinclair C, McPherson G, Schumm K, Burr J, Walton K, Vale L, Buckley B, McDonald A, Grant A, Glazener C, Norrie J & N’Dow JMO. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial of antibiotic and antiseptic impregnated urethral catheters (The Catheter Trial). Health Technology Assessment 2012 Nov; 16(47):1-197. (doi: 10.3310/hta16470).Pickard R, Lam TB, Boachie C, MacLennan G, Kilonzo M, Starr K, Duncan A, Pflanz-Sinclair C, McPherson G, Schumm K, Burr J, Walton K, Vale L, Buckley B, McDonald A, Grant A, Glazener C, Norrie J & N’Dow JMO. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial of antibiotic and antiseptic impregnated urethral catheters (The Catheter Trial). Health Technology Assessment 2012 Nov; 16(47):1-197. (doi: 10.3310/hta16470).

Laing KA, Lam TB, McClinton S, Cohen NP, Traxer O, Somani BK. Outcomes of ureteroscopy for stone disease in pregnancy: results from a systematic review of the literature. Urol Int. 2012; 89(4):380-6. (doi: 10.1159/000343732).Laing KA, Lam TB, McClinton S, Cohen NP, Traxer O, Somani BK. Outcomes of ureteroscopy for stone disease in pregnancy: results from a systematic review of the literature. Urol Int. 2012; 89(4):380-6. (doi: 10.1159/000343732).Laing KA, Lam TB, McClinton S, Cohen NP, Traxer O, Somani BK. Outcomes of ureteroscopy for stone disease in pregnancy: results from a systematic review of the literature. Urol Int. 2012; 89(4):380-6. (doi: 10.1159/000343732).Laing KA, Lam TB, McClinton S, Cohen NP, Traxer O, Somani BK. Outcomes of ureteroscopy for stone disease in pregnancy: results from a systematic review of the literature. Urol Int. 2012; 89(4):380-6. (doi: 10.1159/000343732).

Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, Barocas DA, Eden CG, Fraser C, Gurung T, Jenkinson D, Jia X, Lam TB, Mowatt G, Neal DE, Robinson MC, Royle J, Rushton SP, Sharma P, Shirley MD, Soomro N. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess. 2012; 16(41):1-313. (doi: 10.3310/hta16410).Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, Barocas DA, Eden CG, Fraser C, Gurung T, Jenkinson D, Jia X, Lam TB, Mowatt G, Neal DE, Robinson MC, Royle J, Rushton SP, Sharma P, Shirley MD, Soomro N. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess. 2012; 16(41):1-313. (doi: 10.3310/hta16410).Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, Barocas DA, Eden CG, Fraser C, Gurung T, Jenkinson D, Jia X, Lam TB, Mowatt G, Neal DE, Robinson MC, Royle J, Rushton SP, Sharma P, Shirley MD, Soomro N. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess. 2012; 16(41):1-313. (doi: 10.3310/hta16410).Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, Barocas DA, Eden CG, Fraser C, Gurung T, Jenkinson D, Jia X, Lam TB, Mowatt G, Neal DE, Robinson MC, Royle J, Rushton SP, Sharma P, Shirley MD, Soomro N. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess. 2012; 16(41):1-313. (doi: 10.3310/hta16410).

MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Dahm P, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012 Dec; 62(6):1097-117. (doi: 10.1016/j.eururo.2012.07.028).MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Dahm P, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012 Dec; 62(6):1097-117. (doi: 10.1016/j.eururo.2012.07.028).MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Dahm P, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012 Dec; 62(6):1097-117. (doi: 10.1016/j.eururo.2012.07.028).MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Dahm P, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012 Dec; 62(6):1097-117. (doi: 10.1016/j.eururo.2012.07.028).

Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2012 Oct 16. (doi:pii: S0022-5347(12)05248-2. 10.1016/j.juro.2012.10.022) [Epub ahead of print].Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2012 Oct 16. (doi:pii: S0022-5347(12)05248-2. 10.1016/j.juro.2012.10.022) [Epub ahead of print].Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2012 Oct 16. (doi:pii: S0022-5347(12)05248-2. 10.1016/j.juro.2012.10.022) [Epub ahead of print].Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2012 Oct 16. (doi:pii: S0022-5347(12)05248-2. 10.1016/j.juro.2012.10.022) [Epub ahead of print].

Mamoulakis C, Sofras F, de la Rosette J, Omar MI, Lam TBL, N’Dow JMO, Ubbink DT. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009629 (doi: 10.1002/14651858.CD009629).Mamoulakis C, Sofras F, de la Rosette J, Omar MI, Lam TBL, N’Dow JMO, Ubbink DT. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009629 (doi: 10.1002/14651858.CD009629).Mamoulakis C, Sofras F, de la Rosette J, Omar MI, Lam TBL, N’Dow JMO, Ubbink DT. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009629 (doi: 10.1002/14651858.CD009629).Mamoulakis C, Sofras F, de la Rosette J, Omar MI, Lam TBL, N’Dow JMO, Ubbink DT. Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction. (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009629 (doi: 10.1002/14651858.CD009629).

MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J, UCAN Systematic Review Reference Group, and the EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. European Urology 2012; 61(5):972-93. MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J, UCAN Systematic Review Reference Group, and the EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. European Urology 2012; 61(5):972-93. MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J, UCAN Systematic Review Reference Group, and the EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. European Urology 2012; 61(5):972-93. MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J, UCAN Systematic Review Reference Group, and the EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. European Urology 2012; 61(5):972-93.

Imamura M, MacLennan S, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N’Dow J, UCAN Systematic Review Reference Group, and the EAU Renal Cancer Guideline Panel. Systematic review of the clinical effectiveness of surgical management for localised renal cell carcinoma. University of Aberdeen, Academic Urology Unit, 2011. Aberdeen, UK. Available from: http://www.uroweb.org/?id=217&tyid=1&oid=4.

Lam TBL, Regnier-Coudert O, McCall J, McClinton S. Development and validation of a UK-specific prostate cancer staging predictive model: UK prostate cancer tables. British Journal of Medical and Surgical Urology 2012; 5(5):224-35. Lam TBL, Regnier-Coudert O, McCall J, McClinton S. Development and validation of a UK-specific prostate cancer staging predictive model: UK prostate cancer tables. British Journal of Medical and Surgical Urology 2012; 5(5):224-35. Lam TBL, Regnier-Coudert O, McCall J, McClinton S. Development and validation of a UK-specific prostate cancer staging predictive model: UK prostate cancer tables. British Journal of Medical and Surgical Urology 2012; 5(5):224-35.

Dospinescu C, Lam TBL, Kurban L, Cohen NP and Swami SK. Acute pancreatitis induced by an obstructing left ureteric calculus. British Journal of Medical and Surgical Urology 2012; 5:292-3. (doi: 10.1016/j.bjmsu.2011.11.006) .Dospinescu C, Lam TBL, Kurban L, Cohen NP and Swami SK. Acute pancreatitis induced by an obstructing left ureteric calculus. British Journal of Medical and Surgical Urology 2012; 5:292-3. (doi: 10.1016/j.bjmsu.2011.11.006) .Dospinescu C, Lam TBL, Kurban L, Cohen NP and Swami SK. Acute pancreatitis induced by an obstructing left ureteric calculus. British Journal of Medical and Surgical Urology 2012; 5:292-3. (doi: 10.1016/j.bjmsu.2011.11.006) .

Regnier-Coudert O, McCall J, Lothian R, Lam T, McClinton S, N’Dow J. Machine learning for improved pathological staging of prostate cancer: A performance comparison on a range of classifiers. Artificial Intelligence in Medicine 2012; 55(1):25-35.Regnier-Coudert O, McCall J, Lothian R, Lam T, McClinton S, N’Dow J. Machine learning for improved pathological staging of prostate cancer: A performance comparison on a range of classifiers. Artificial Intelligence in Medicine 2012; 55(1):25-35.Regnier-Coudert O, McCall J, Lothian R, Lam T, McClinton S, N’Dow J. Machine learning for improved pathological staging of prostate cancer: A performance comparison on a range of classifiers. Artificial Intelligence in Medicine 2012; 55(1):25-35.

Mishriki SF, Vint R, Somani BK. Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup. J Urol 2012;187(5):1561-5.Mishriki SF, Vint R, Somani BK. Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup. J Urol 2012;187(5):1561-5.Mishriki SF, Vint R, Somani BK. Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup. J Urol 2012;187(5):1561-5.

Mishriki SF, Vint R, Somani BK. Half of Visible and Half of Recurrent Visible Hematuria Cases have Underlying Pathology: Prospective Large Cohort Study with Long-Term Follow-Up. J Urol. 2012; (12)-7. [Epub ahead of print]Mishriki SF, Vint R, Somani BK. Half of Visible and Half of Recurrent Visible Hematuria Cases have Underlying Pathology: Prospective Large Cohort Study with Long-Term Follow-Up. J Urol. 2012; (12)-7. [Epub ahead of print]Mishriki SF, Vint R, Somani BK. Half of Visible and Half of Recurrent Visible Hematuria Cases have Underlying Pathology: Prospective Large Cohort Study with Long-Term Follow-Up. J Urol. 2012; (12)-7. [Epub ahead of print]

Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2013 ; (81): 390-4Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2013 ; (81): 390-4Mishriki SF, Aboumarzouk O, Vint R, Grimsley SJ, Lam T, Somani B. Routine urine cytology has no role in hematuria investigations. J Urol. 2013 ; (81): 390-4

Mostafa, Alyaa; Agur, Wael; Abdel-All, Mohamed; Guerrero, Karen; Lim, Chi; Allam, Mohammed; Yousef, Mohamed; N’Dow, James; Abdel-Fattah, Mohamed. A multicentre prospective randomised study of single-incision mini-sling (Ajust ®) versus tension-free vaginal tape-obturator (TVT-O™) in the management of female stress urinary incontinence: pain profile and short-term outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology 2012, Vol. 165, No. 1, p. 115-121.

Abdel-fattah, Mohamed; Mostafa, Alyaa; Familusi, Akinbowale; Ramsay, Ian; N’Dow, James. Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3-year outcomes from the Evaluation of Transobturator Tapes study. European Urology 2012; Vol. 62, No. 5, p. 843-851.

Mariappan, Paramananthan; Finney, Steven M; Head, Elizabeth; Somani, Bhaskar K; Zachou, Alexandra; Smith, Gordon; Mishriki, Said F; N’Dow, James; Grigor, Kenneth M; Edinburgh Urological Cancer Group. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU International 2012; Vol. 109, No. 11, p. 1666-1673.
Mohamad, H.; Craig, L. C. A. ; Heys, S. D. ; McNeill, G.; N’Dow, J. ; Clark, J. Provision of a healthy weight maintenance programme for men treated for prostate cancer : a study of patients’ preferences. Proceedings of the Nutrition Society 2012; Vol. 71, No. OCE1, p. E2.

2011

Ahmad, S., Manecksha, R., Cullen, I., et al. “Estimation of clinically significant prostate volumes by digital rectal examination – a comparative prospective study.” Can J Urol 18(6):6025-30. Dec. 2011

Ahmad, S., Casey, G., Cronin, M., et al.”Induction of effective anti-tumour responses following mucosal bacterial vector mediated DNA vaccination with an endogenous prostate cancer specific antigen.” J Urol 186 (2):687-93. doi: 10.1016/j.juro.2011.03.139. Aug 2011

Cullen, I. M., Manecksha, R. P., McCullagh, E., Ahmad, S., et al.”The changing pattern of antimicrobial resistance within 42033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 199 -2009.” BJU Int. 109 (8):1198-206. doi: 10.1111/j.1464-410X.2011.10528.x. Aug 2011Cullen, I. M., Manecksha, R. P., McCullagh, E., Ahmad, S., et al.”The changing pattern of antimicrobial resistance within 42033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 199 -2009.” BJU Int. 109 (8):1198-206. doi: 10.1111/j.1464-410X.2011.10528.x. Aug 2011Cullen, I. M., Manecksha, R. P., McCullagh, E., Ahmad, S., et al.”The changing pattern of antimicrobial resistance within 42033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 199 -2009.” BJU Int. 109 (8):1198-206. doi: 10.1111/j.1464-410X.2011.10528.x. Aug 2011

Ahmad, S., Manecksha, R., Hayes, BD., et al.”Case report of a symptomatic giant renal oncocytoma.” Int J Surg Case Rep 2 (6):83-5. doi: 10.1016/j.ijscr.2010.11.006. March 2011

Mishriki SF, Grimsley S, Lam T, Nabi G & Cohen NP. TURP and sex: Patient and partner prospective 12 years follow-up study. BJU International 2011; 109:745-50.Mishriki SF, Grimsley S, Lam T, Nabi G & Cohen NP. TURP and sex: Patient and partner prospective 12 years follow-up study. BJU International 2011; 109:745-50.Mishriki SF, Grimsley S, Lam T, Nabi G & Cohen NP. TURP and sex: Patient and partner prospective 12 years follow-up study. BJU International 2011; 109:745-50.

Omar MI, Lam TBL & N’Dow J. Transurethral Resection of the Prostate (TURP) – Gold standard in an uncertain environment. Urology News 2011; 15(4):6-9.Omar MI, Lam TBL & N’Dow J. Transurethral Resection of the Prostate (TURP) – Gold standard in an uncertain environment. Urology News 2011; 15(4):6-9.

Maclennan SJ, Maclennan SJ, Imamura M, Omar MI, Vale L, Lam T, Royle P, Royle J, Swami S, Pickard R, McClinton S, Griffiths TR, Dahm P, N’dow J; and the UCAN Care Pathway Development Group. Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World Journal of Urology 2011; 29(3):291-301.Maclennan SJ, Maclennan SJ, Imamura M, Omar MI, Vale L, Lam T, Royle P, Royle J, Swami S, Pickard R, McClinton S, Griffiths TR, Dahm P, N’dow J; and the UCAN Care Pathway Development Group. Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World Journal of Urology 2011; 29(3):291-301.
Swami KS, Lam T & Nabi G. A novel circumferential bladder neck suture to facilitate vesico-urethral anastomosis during radical retropubic prostatectomy. BJU International 2011; 107(12):2006-10 (doi 10.1111/j.1464-410X.2011.10383.x).Swami KS, Lam T & Nabi G. A novel circumferential bladder neck suture to facilitate vesico-urethral anastomosis during radical retropubic prostatectomy. BJU International 2011; 107(12):2006-10 (doi 10.1111/j.1464-410X.2011.10383.x).

Mishriki SF, Grimsley SJS, Lam T, Nabi G, Cohen NP. TURP and Sex: Patient and Partner Prospective 12 years Follow-up Study. BJUI 2011; 109(5): 745-50. Epub 28 June 2011.

Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G, Mishriki SF, N’dow J, Grigor KM; for members of the Edinburgh Urological Cancer Group. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int. 2011 Nov 1. [Epub ahead of print]Mariappan P, Finney SM, Head E, Somani BK, Zachou A, Smith G, Mishriki SF, N’dow J, Grigor KM; for members of the Edinburgh Urological Cancer Group. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. BJU Int. 2011 Nov 1. [Epub ahead of print]

Rai BP, Shelley M, Coles B, Biyani CS, El-Mokadem I, Nabi G. Surgical management of upper tract Transitional Cell Carcinoma. Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007349.doi: 10.1002/14651858.CD007349.pub2. PMID: 21491399

2010

Schumm K, Skea Z, McKee L, N’Dow J. ‘They’re doing surgery on two people’: A meta-ethnography of the influences on couples’ treatment decision making for prostate cancer. Health Expectations 2010;13:335-49.

Imamura M, Abrams P, Bain C, Buckley B, Cardozo L, Cody J et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technology Assessment 2010;14:1-188.

Imamura M, Cook J, Maclennan S, N’Dow J, Dahm P, Evidence-Based Urology Working Group. Evidence-based urology in practice: heterogeneity in a systematic review meta-analysis. BJU International 2010;105:770-3.

Imamura M, Williams K, Wells M, McGrother C. Lifestyle interventions for the treatment of urinary incontinence in adults [Protocol]. Cochrane Database of Systematic Reviews 2010;

Somani BK, MacLennan SJ, N’Dow J. Quality of Life With Urinary Diversion. European Urology Supplements 2010;9:763-71.

2009

Armstrong N, Vale L, Deverill M, Nabi G, McClinton S, N’Dow J et al. Surgical treatments for men with benign prostatic enlargement: cost effectiveness study. British Medical Journal 2009;338:b1288.

2008

Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G et al. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. British Medical Journal 2008;337:a1662.

Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. Cochrane Database of Systematic Reviews2008;337:a449.

Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. [Update of Cochrane Database Syst Rev. 2004;(1):CD004013; PMID: 14974052]. Cochrane Database of Systematic Reviews2008;CD004013.

Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review. Neurourology & Urodynamics 2008;27:738-46.

Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N’Dow J et al. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. Journal of Urology 2008;179:1844-9.

Wilt TJ, N’Dow J. Benign prostatic hyperplasia. Part 1–diagnosis. British Medical Journal 2008;336:146-9.

Wilt TJ, N’Dow J. Benign prostatic hyperplasia. Part 2–management. British Medical Journal 2008;336:206-10.

2007

Mackie S, Lam T, Rai B, Nabi G, McClinton S. Management of urological hemorrhage and the role of transarterial angioembolization. Minerva Medica 2007;98:511-24.

Mariappan P, Alhasso A, Ballantyne Z, Grant A, N’Dow J. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. [Review] [28 refs]. European Urology 2007;51:67-74.

N’Dow J, Kirk,D, Brown,M, Dickson,L, El-Ghorr,A, Fraser,M et al. Urology Patient Pathways. NHS Scotland; 2007 [accessed ]. http://www.pathways.scot.nhs.uk/urology.htm.

Nabi G, Cook J, N’Dow J, McClinton S. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. British Medical Journal 2007;334:572.

Somani BK, Kumar V, Wong S, Pickard R, Ramsay C, Nabi G et al. Bowel Dysfunction After Transposition of Intestinal Segments Into the Urinary Tract: 8-Year Prospective Cohort Study. Journal of Urology 2007;177:1793-8.

2006

Somani BK, Prita D, Grant S, Nabi G, N’Dow J. Herpetiform cutaneous metastases from transitional cell carcinoma of the urinary bladder: immunohistochemical analysis. Journal of Clinical Pathology 2006;59:1331-3.

Lam T, Nabi G. Potential of urinary biomarkers in early bladder cancer diagnosis. Expert Review of Anticancer Therapy2007;7:1105-15.

Phipps S, Lim YN, McClinton S, Barry C, Rane A, N’Dow J. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database of Systematic Reviews 2006;CD004374.

Shaikh S, Ong EK, Glavind K, Cook J, N’Dow JM. Mechanical devices for urinary incontinence in women. [Update in Cochrane Database Syst Rev. 2006;3:CD001756; PMID: 16855977]. Cochrane Database of Systematic Reviews 2006;CD001756.

2005

Alhasso A, Glazener CM, Pickard R, N’Dow J. Adrenergic drugs for urinary incontinence in adults. [Update of Cochrane Database Syst Rev. 2003;(2):CD001842; PMID: 12804414]. Cochrane Database of Systematic Reviews 2005;CD001842.

Mariappan P, Ballantyne Z, N’Dow JM, Alhasso AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews 2005;

N’Dow J, Jordan N, Robson CN, Neal DE, Pearson JP. The bladder does not appear to have a dynamic secreted continuous mucous gel layer. Journal of Urology 2005;173:2025-31.

Nabi G, Yong SM, Ong E, McPherson G, Grant A, N’Dow J. Is orthotopic bladder replacement the new gold standard? Evidence from a systematic review. Journal of Urology 2005;174:21-8.

Nabi G, N’Dow J, Hasan TS, Booth IR, Cash P. Proteomic analysis of urine in patients with intestinal segments transposed into the urinary tract. Proteomics 2005;5:1729-33.

2004

N’Dow J, Pearson J, Neal D. Mucus production after transposition of intestinal segments into the urinary tract. World Journal of Urology 2004;22:178-85..

2003

Alhasso A, Glazener CM, Pickard R, N’Dow J. Adrenergic drugs for urinary incontinence in adults. [Update in Cochrane Database Syst Rev. 2005;(3):CD001842; PMID: 16034867]. Cochrane Database of Systematic Reviews 2003;CD001842.

Keegan SJ, Graham C, Neal DE, Blum-Oehler G, N’Dow J, Pearson JP et al. Characterization of Escherichia Coli Strains Causing Urinary Tract Infections in Patients With Transposed Intestinal Segments. Journal of Urology 2003;169:2382-7.

Yong SM, Dublin N, Pickard R, Cody DJ, Neal DE, N’Dow J. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database of Systematic Reviews2003;CD003306.

2001

Lourenco T, Armstrong N, N’Dow J, Nabi G, Deverill M, Pickard R et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. [Review] [289 refs]. Health Technology Assessment 2001;12:iii-iix.

N’Dow J, Robson CN, Matthews JN, Neal DE, Pearson JP. Reducing mucus production after urinary reconstruction: a prospective randomized trial.[Erratum appears in J Urol 2001 Jul;166(1):220]. Journal of Urology 2001;165:1433-40.

2000

N’Dow J, Pearson JP, Bennett MK, Neal DE, Robson CN. Mucin gene expression in human urothelium and in intestinal segments transposed into the urinary tract. Journal of Urology 2000;164:1398-404.

1998

N’Dow J, N’Dow K, Maffulli N, Page G. The suspected scaphoid fracture. How useful is a unit policy? Bulletin of the Hospital for Joint Diseases 1998;57:93-5.

1997

N’Dow J, Pearson JP, Neal DE, Robson CN. Does normal urine contain mucin? British Journal of Urology 1997;1997:161-2.

N’Dow J, Neal DE. Female adult reconstructive urology. British Journal of Urology 1997;80:Suppl-78.

1993

N’Dow J, Brown PA, McClinton S, Moffat LE, Grieve JH. Inflammatory pseudotumour of the urinary bladder. British Journal of Urology 1993;72:379-80.